Is there variability in drug release and physical characteristics of amiodarone chloride from different commercially available tablets? Possible therapeutic implications

International Journal of Pharmacy Practice

Volumn 18, Issue 4, 2010, Pages 245-248

  Ngo, Suong N T ^a   Barnes, Timothy ^b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

amiodarone; drug release; pharmaceutical dosage forms; physical characteristics

Indexed keywords

AMIODARONE; GENERIC DRUG;

ARTICLE; BIOEQUIVALENCE; DISSOLUTION; DRUG ANALYSIS; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; HIGH TEMPERATURE; HUMAN; PRIORITY JOURNAL;

AMIODARONE; ANTI-ARRHYTHMIA AGENTS; AUSTRALIA; BIOLOGICAL AVAILABILITY; DRUG STABILITY; DRUG STORAGE; DRUGS, GENERIC; HARDNESS; HUMIDITY; PHARMACOPOEIAS AS TOPIC; SOLUBILITY; TABLETS; TEMPERATURE; UNITED STATES;

EID: 77954732540     PISSN: 09617671     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7174.2010.00037.x     Document Type: Article

References (10)

1. Ngo SNT. When do differences in dissolution profiles predict clinical problems? J Clin Pharm Ther 2007 32 : 111 112.
2. Wu CY, Benet LZ. Predicting drug disposition via application of BCS: transport/absorption/elimination interplay and development of a Biopharmaceutics drug disposition classification system. Pharm Res 2005 22 : 11 23.
3. US Food and Drug Administration, Center for Drug Evaluation and Research. Guidance for Industry: Bioavailability and Bioequivalence Studies for Orally Administered Drug Products General Considerations.
4. World Health Organization. Multisource (Generic) Pharmaceutical Products: Guidelines on Registration Requirements to Establish Interchangeability.
5. Besag FMC. Is generic prescribing acceptable in epilepsy? Drug Safety 2000 23 : 173 182.
6. Mofsen R, Balter J. Case reports of the re-emergence of psychotic symptoms after conversion from brand-name clozapine to a generic formulation. Clin Ther 2001 23 : 1720 1731.
7. Reiffel JA. Formulation substitution: a frequently overlooked variable in cardiovascular drug management. Prog Cardiovasc Dis 2004 47 : 3 10.
8. Reiffel JA, Kowey PR. Generic antiarrhythmics are not therapeutically equivalent for treatment of tachyarrhythmias. Am J Cardiol 2000 85 : 1151 1153.
9. Pollak PT. Altered metabolite concentrations with amiodarone substitution cannot be observed without monitoring. Can J Cardiol 2001 17 : 1159 1163.
10. United States Pharmacopeia. United States Pharmacopeia 27, National Formulary.